[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590930":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":31,"responsibleParty":45,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with pituitary tumors",null,"Patients with pituitary tumors, underwent surgical resection",[13],"Other: Frequency of disease recurrence",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Frequency of disease recurrence","To collect data of pituitary disease recurrence",[9],[20],{"name":21,"affiliation":5,"role":22},"Francesco Doglietto, Prof","PRINCIPAL_INVESTIGATOR",[24,28],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","+390630155701","francesco.doglietto@policlinicogemelli.it",{"name":29,"role":25,"phone":10,"phoneExt":10,"email":30},"Sabrina Chiloiro, MD","sabrina.chiloiro@policlinicogemelli.it",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":36,"cosmosGeoPoint":39,"geoPoint":44,"contacts":10},"Fondazione Policlinico Gemelli IRCCS","RECRUITING","Rome","IT","00168","Italy",{"type":40,"coordinates":41},"Point",[42,43],12.51133,41.89193,{"lat":43,"lon":42},{"type":22,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Doglietto Francesco","Professor","100590930","a-twenty-years-experience-in-pituitary-disease-100590930",false,"NCT06973824","A Twenty-years' Experience in Pituitary Disease.","A Twenty-years' Experience in Pituitary Disease: Identification of Prognostic Factors in Pituitary Tumors","TYEPDD","Inclusion Criteria:\n\n* Patients underwent surgery for pituitary tumors;\n* pathology diagnosis of pituitary tumors;\n* patients older then 18 years at diagnosis of pituitary tumors;\n* 2 years follow-up;\n\nExclusion Criteria:\n\n* age lower then 18 years\n* follow-up shorter than 2 years","ALL","18 Years",{"count":59,"type":60},1600,"ESTIMATED","OBSERVATIONAL","Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningiomas, craniopharyngiomas, germosomes and tumours secondary, such as metastases and lymphomas. Since these conditions are considered rare, the data epidemiology and prognosis to predict the natural history of these diseases can not be considered conclusive. Pituitary adenomas are a useful model for epidemiology in the study of pathology pituitary. Over the past 20 years, several attempts have been made to identify unique prognostic factors, which predict the outcome of these pathologies, but without To arrive at a definitive classification. The purpose of this study aims to collect clinical, biochemical, morphological and pathological data on the retrospective and prospective cohort of over 1600 patients undergoing neurosurgical removal of pituitary tumors in the last 20 years, to develop a prognostic classification.",[64,65,66],"Pituitary Adenoma","Pituitary Cancer","Pituitary Disease","2025-05-07",{"date":69,"type":70},"2025-05-15","ACTUAL",{"date":72,"type":70},"2025-03-10",{"date":74,"type":60},"2028-04-30",{"name":5,"class":6},1]